PHARMACOTHERAPEUTIC FOLLOW-UP OF A PATIENT WITH MULTIMORBITIES: EXPERIENCE REPORT
Chronic non-communicable diseases are growing global health problems. The objective of this study was to promote pharmaceutical care for a patient with multimorbidities in order to improve its quality of life. A pharmacotherapeutic follow-up was performed using the SOAP method, registered in the for...
| Autores: | , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2023 |
| País: | Brasil |
| Institución: | Universidade Paranaense (UNIPAR) |
| Repositorio: | Arquivos de Ciências da Saúde da UNIPAR (Online) |
| Idioma: | portugués |
| OAI Identifier: | oai:ojs2.revistas.unipar.br:article/9332 |
| Acceso en línea: | https://revistas.unipar.br/index.php/saude/article/view/9332 |
| Access Level: | acceso abierto |
| Palabra clave: | Chronic Noncommunicable Diseases Multimorbidity Pharmaceutical Care |
| Sumario: | Chronic non-communicable diseases are growing global health problems. The objective of this study was to promote pharmaceutical care for a patient with multimorbidities in order to improve its quality of life. A pharmacotherapeutic follow-up was performed using the SOAP method, registered in the form of clinical evolution, along with laboratory tests, anthropometric measurements and application of validated instruments to assess pharmacological adherence, mental health and quality of life. The report deals with a female patient, 55 years old, obese and dyslipidemic, sedentary, hypertensive, diabetic and on the control phase of breast cancer. Self-medication with antibiotics and a proton pump inhibitor was identified. Despite the good pharmacological adherence, the patient had decompensated diabetes, accompanied by dyslipidemia without treatment and interruption of supplements. After pharmacological and non-pharmacological interventions, the patient showed a significant improvement in the reduction of anthropometric measurements and in biochemical parameters. At the end of the follow-up, pharmaceutical care proved to be fundamental in identifying the patient's health problems, contributing to obtain a more rational pharmacotherapy. |
|---|